empire777 login

คาสิโนออนไลน์ เครดิตฟรี _สมัคร w88 ไม่ได้ _สมัครได้เงินฟรี_คาสิโนออนไลน์ โปรโมชั่น โบนัส_เล่นเกมออนไลน์ฟรี

A bill to amend the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program and to provide for sickle cell disease research, surveillance, prevention, and treatment.

The bill’s titles are written by its sponsor.

Sponsor and status

Tim Scott

Sponsor. Junior Senator for South Carolina. Republican.

Read Text »
Last Updated: Dec 13, 2018
Length: 3 pages
Introduced:

Feb 28, 2018

Status:

Passed House & Senate (President next) on Dec 11, 2018

This bill was passed by Congress on December 11, 2018 and goes to the President next.

Prognosis:

48% chance of being enacted according to Skopos Labs (details)

What stakeholders are saying

Institute for Spending Reform: SpendingTracker.org estimates S. 2465 will add $123 million in new spending through 2023.

History

Feb 28, 2018
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Jul 25, 2018
 
Ordered Reported

A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

Oct 11, 2018
 
Passed Senate (House next)

The bill was passed in a vote in the Senate. It goes to the House next. The vote was by Voice Vote so no record of individual votes was made.

Dec 6, 2018
 
On House Schedule

The House indicated that this bill would be considered in the week ahead.

Dec 11, 2018
 
Passed House

The bill was passed by both chambers in identical form. It goes to the President next who may sign or veto the bill. The vote was by voice vote so no record of individual votes was made.

If this bill has further action, the following steps may occur next:
 
Signed by the President

S. 2465 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“S. 2465 — 115th Congress: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of ...” www.GovTrack.us. 2018. December 15, 2018 <https://www.govtrack.us/congress/bills/115/s2465>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.